203 related articles for article (PubMed ID: 3264193)
21. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation.
Boncler MA; Golanski J; Paczuski R; Watala C
J Mol Med (Berl); 2002 Dec; 80(12):796-801. PubMed ID: 12483465
[TBL] [Abstract][Full Text] [Related]
23. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
24. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
25. Increased shear stress- and ristocetin-induced binding of von Willebrand factor to platelets in cord compared with adult plasma.
Rehak T; Cvirn G; Gallistl S; Leschnik B; Köstenberger M; Katzer H; Ribitsch V; Muntean W
Thromb Haemost; 2004 Oct; 92(4):682-7. PubMed ID: 15467896
[TBL] [Abstract][Full Text] [Related]
26. Enhanced ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib in patients with steroid-responsive nephrotic syndrome.
Taira K; Kamitsuji H; Okajima C; Fujimura Y
Haemostasis; 1990; 20(4):219-28. PubMed ID: 2242824
[TBL] [Abstract][Full Text] [Related]
27. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
28. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
29. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
[TBL] [Abstract][Full Text] [Related]
30. Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress.
McCrary JK; Nolasco LH; Hellums JD; Kroll MH; Turner NA; Moake JL
Ann Biomed Eng; 1995; 23(6):787-93. PubMed ID: 8572428
[TBL] [Abstract][Full Text] [Related]
31. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Willebrand factor.
Ozaki Y; Satoh K; Yatomi Y; Miura S; Fujimura Y; Kume S
Biochim Biophys Acta; 1995 Apr; 1243(3):482-8. PubMed ID: 7537105
[TBL] [Abstract][Full Text] [Related]
32. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
[TBL] [Abstract][Full Text] [Related]
33. von Willebrand factor is present on the surface of platelets stimulated in plasma by ADP.
Adelman B; Carlson P; Powers P
Blood; 1987 Nov; 70(5):1362-6. PubMed ID: 2822171
[TBL] [Abstract][Full Text] [Related]
34. Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GPIb, platelet retention, and thrombus formation in vivo.
Kawasaki T; Kaku S; Kohinata T; Sakai Y; Taniuchi Y; Kawamura K; Yano S; Takenaka T; Fujimura Y
Am J Hematol; 1994 Sep; 47(1):6-15. PubMed ID: 8042618
[TBL] [Abstract][Full Text] [Related]
35. Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor.
Sixma JJ; Ijsseldijk MJ; Hindriks G; van Zanten GH; Gorecki M; Panet A; Garfinkel LI; de Groot PG
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):64-71. PubMed ID: 8548428
[TBL] [Abstract][Full Text] [Related]
36. Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size.
Federici AB; Bader R; Pagani S; Colibretti ML; De Marco L; Mannucci PM
Br J Haematol; 1989 Sep; 73(1):93-9. PubMed ID: 2803984
[TBL] [Abstract][Full Text] [Related]
37. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
Kao KJ; Pizzo SV; McKee PA
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
[TBL] [Abstract][Full Text] [Related]
38. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
[TBL] [Abstract][Full Text] [Related]
39. Identification of receptors for fibrinogen and von Willebrand factor mediating aggregation in guinea pig platelets.
Kupinski JM; Miller JL
Thromb Res; 1986 Aug; 43(3):335-44. PubMed ID: 3016944
[TBL] [Abstract][Full Text] [Related]
40. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
Olson JD; Zaleski A; Herrmann D; Flood PA
J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
